Correlation Engine 2.0
Clear Search sequence regions


  • basal cell carcinoma (1)
  • biogenesis (1)
  • breast cancer (1)
  • factors (1)
  • Gli (1)
  • hedgehog proteins (2)
  • Hh (10)
  • humans (1)
  • libraries (2)
  • ligands (1)
  • multiple myeloma (1)
  • Ptch (1)
  • receptors (1)
  • research (1)
  • signal (1)
  • Smo (1)
  • Sizes of these terms reflect their relevance to your search.

    The Hedgehog (Hh) signaling pathway plays a crucial role in diverse biological processes such as cell differentiation, proliferation, senescence, tumorigenesis, malignant transformation, and drug resistance. Aberrant Hh signaling, resulting from mutations and excessive activation, can contribute to the development of various diseases during different stages of biogenesis and development. Moreover, it has been linked to unfavorable outcomes in several human cancers, including basal cell carcinoma (BCC), multiple myeloma (MM), melanoma, and breast cancer. Hence, the presence of mutations and excessive activation of the Hh pathway presents obstacles and constraints in the realm of cancer treatment. Extant research has demonstrated that small molecule inhibitors are regarded as the most effective therapeutic approaches for targeting the Hh pathway in contrast to traditional chemotherapy and radiotherapy. Consequently, this review focuses on the present repertoire of small molecule inhibitors that target various components of the Hh pathway, including Hh ligands, Ptch receptors, Smo transmembrane proteins, and Gli nuclear transcription factors. This study provides a comprehensive analysis of small molecules' structural and functional aspects in the preclinical and clinical management of cancer. Additionally, it elucidates the obstacles encountered in targeting the Hh pathway for human cancer therapy and proposes potential therapeutic approaches. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

    Citation

    Xiaotang Wang, Tian Wang, Xiaona Song, Jiping Gao, Guoqiang Xu, Yunhui Ma, Guohua Song. Current Status of Hedgehog Signaling Inhibitors. Current topics in medicinal chemistry. 2024;24(3):243-258

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38231069

    View Full Text